Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokinetics
Sign Up to like & getrecommendations! Published in 2024 at "Immunotherapy"
DOI: 10.1080/1750743x.2024.2382081
Abstract: Abstract Immunoglobulin G (IgG) therapies have been used for decades as standard treatment for patients with primary antibody deficiencies. Monitoring the pharmacokinetics (PK) of IgG is a key component in guiding treatment regimens. Despite the… read more here.
Keywords: therapies primary; part understanding; primary immunodeficiency; diseases part ... See more keywords
Ocular manifestations of dermatological diseases part II: genodermatoses.
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Dermatology"
DOI: 10.1111/ijd.15173
Abstract: Skin and eyes share a common embryological origin from the embryonic surface ectoderm. Ocular manifestations in dermatological diseases are common and have diagnostic value. At present, there are a limited number of comprehensive reviews emphasizing… read more here.
Keywords: dermatological diseases; dermatology; manifestations dermatological; ocular manifestations ... See more keywords